- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2017
- Public Summary Document (PSD) July 2017 PBAC Meeting - PDF
- Public Summary Document (PSD) July 2017 PBAC Meeting - Word
Evolocumab – July 2017
Evolocumab: Injection 420 mg in 3.5 mL, single dose autoinjector; Repatha®
Last updated
27 October 2017